Haemonetics Corp. (HAE)
58.69
-0.84
(-1.41%)
USD |
NYSE |
Apr 09, 10:52
Haemonetics Market Cap : 2.727B for April 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Boston Scientific Corp. | 90.55B |
| Edwards Lifesciences Corp. | 46.41B |
| QuidelOrtho Corp. | 972.89M |
| Stryker Corp. | 128.31B |
| Zimmer Biomet Holdings, Inc. | 18.11B |
Market Cap Related Metrics
| PE Ratio | 16.12 |
| PS Ratio | 2.141 |
| PEG Ratio | 0.3729 |
| Price to Book Value | 2.991 |
| Price to Free Cash Flow | 9.162 |
| Price | 58.69 |
| Earnings Yield | 6.20% |
| PEGY Ratio | 0.3729 |
| Operating PE Ratio | 11.60 |
| Normalized PE Ratio | 16.09 |